NRAS and myelodysplastic syndrome: To summarize, our results showed that patients with ASXL1mt manifested with a worse CR rate, and an inferior OS was observed in patients with MDS, co‐mutations of RUNX1, SRSF2, or NRAS, and mutations in G646W.